Grasping time - longevity of vascularized composite allografts.
Journal
Current opinion in organ transplantation
ISSN: 1531-7013
Titre abrégé: Curr Opin Organ Transplant
Pays: United States
ID NLM: 9717388
Informations de publication
Date de publication:
24 Oct 2024
24 Oct 2024
Historique:
medline:
29
10
2024
pubmed:
29
10
2024
entrez:
29
10
2024
Statut:
aheadofprint
Résumé
Despite significant advancements in the field of vascularized composite allotransplantation, challenges, particularly regarding the long-term viability and functionality of vascularized composite allotransplantation (VCA) grafts, persist. This paper provides a review of the current literature on the longevity of VCA grafts, focusing on factors influencing graft survival, immunological considerations and clinical outcomes. Longevity of VCA grafts is influenced by a variety of peri- and postoperative factors including cold ischemia time, human leukocyte antigen matching, environmental exposure, psychosocial factors, adherence, immunosuppression, and complications. Due to the limited number of VCA transplants performed and heterogenous reporting, direct correlation of single factors with VCA outcomes remains inconclusive. Indirect evidence, however, supports their importance. High immunosuppressive burden, frequent occurrence of acute and accumulating cases of chronic rejection remain a significant challenge of the field. Insights gained from this review aim to inform clinical practice and guide future research endeavors with the goal of ameliorating outcomes after VCA transplantation and facilitate wider use of VCA grafts for restoration of tissue defects.
Identifiants
pubmed: 39470048
doi: 10.1097/MOT.0000000000001177
pii: 00075200-990000000-00146
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Références
Poggio ED, Augustine JJ, Arrigain S, et al. Long-term kidney transplant graft survival—making progress when most needed. Am J Transplant 2021; 21:2824–2832.
Studer SM, Levy RD, McNeil K, Orens JB. Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness. Eur Respir J 2004; 24:674–685.
IRHCTT – International Registry on Hand and Composite Tissue Transplantation. n.d. https://www.handregistry.com/ [Accessed August 10, 2024].
Gurunian R, Rampazzo A, Papay F, Gharb BB. Reconstructive transplantation. Cham:Springer; 2023.
Wells MW, Rampazzo A, Papay F, Gharb BB. Two decades of hand transplantation: a systematic review of outcomes. Ann Plast Surg 2022; 88:335–344.
Shores JT, Malek V, Lee WPA, Brandacher G. Outcomes after hand and upper extremity transplantation. J Mater Sci Mater Med 2017; 28:72.
Krezdorn N, Lian CG, Wells M, et al. Chronic rejection of human face allografts. Am J Transplant 2019; 19:1168–1177.
Lantieri L, Grimbert P, Ortonne N, et al. Face transplant: long-term follow-up and results of a prospective open study. Lancet 2016; 388:1398–1407.
Tchiloemba B, Kauke M, Haug V, et al. Long-term outcomes after facial allotransplantation: systematic review of the literature. Transplantation 2021; 105:1869–1880.
Kantar RS, Alfonso AR, Diep GK, et al. Facial transplantation: principles and evolving concepts. Plast Reconstr Surg 2021; 147:1022E–1038E.
Datta N, Devaney SG, Busuttil RW, et al. Prolonged cold ischemia time results in local and remote organ dysfunction in a murine model of vascularized composite transplantation. Am J Transplant 2017; 17:2572–2579.
Messner F, Hautz T, Blumer MJF, et al. Critical ischemia times and the effect of novel preservation solutions htk-n and tiprotec on tissues of a vascularized tissue isograft. Transplantation 2017; 101:e301–e310.
Hautz T, Hickethier T, Blumer MJF, et al. Histomorphometric evaluation of ischemia-reperfusion injury and the effect of preservation solutions histidine-tryptophan-ketoglutarate and university of Wisconsin in limb transplantation. Transplantation 2014; 98:713–720.
UNOS. OPTN/UNOS Vascularized Composite Allograft (VCA) Transplantation Committee Meeting Minutes. 2018.
UNOS/OPTN Vascularized Composite Allograft Transplantation Committee. Eliminate the use of regions in VCA distribution.
Booker SE, Howell J, Dolan TG, et al. Impact of removing OPTN region from vascularized composite allograft allocation. Front Transplant 2024; 3:1399357.
Lozanovski VJ, Döhler B, Weiss KH, et al. The differential influence of cold ischemia time on outcome after liver transplantation for different indications—who is at risk? A collaborative transplant study report. Front Immunol 2020; 11:892.
Debout A, Foucher Y, Trébern-Launay K, et al. Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation. Kidney Int 2015; 87:343–349.
Peters-Sengers H, Houtzager JHE, Idu MM, et al. Impact of cold ischemia time on outcomes of deceased donor kidney transplantation: an analysis of a national registry. Transplant Direct 2019; 5:e448.
Ng ZY, Lellouch AG, Drijkoningen T, et al. Vascularized composite allotransplantation-an emerging concept for burn reconstruction. J Burn Care Res 2017; 38:371–378.
Kim JJ, Fuggle SV, Marks SD. Does HLA matching matter in the modern era of renal transplantation? Pediatric Nephrol 2021; 36:31–40.
Shanmugarajah K, Powell H, Leonard DA, et al. The effect of MHC antigen matching between donors and recipients on skin tolerance of vascularized composite allografts. Am J Transplant 2017; 17:1729–1741.
Hoffman AF, Park JJ, Berman ZP, et al. Establishing a clinically applicable methodology for skin color matching in vascularized composite allotransplantation. Plast Reconstr Surg Glob Open 2020; 8:e2655.
Kumnig M, Jowsey-Gregoire SG, Gordon EJ, Werner-Felmayer G. Psychosocial and bioethical challenges and developments for the future of vascularized composite allotransplantation: a scoping review and viewpoint of recent developments and clinical experiences in the field of vascularized composite allotransplantation. Front Psychol 2022; 13:1045144.
Kumnig M, Jowsey-Gregoire SG, Bellew M, et al. The Chauvet Workgroup: a resource for the psychosocial aspects of reconstructive transplantation. Mayo Clin Proc 2022; 97:1050–1053.
Benedict JL, Barth RN. How to help patients considering VCA. AMA J Ethics 2019; 21:960–967.
Van Pilsum Rasmussen SE, Ferzola A, Cooney CM, et al. Psychosocial factors and medication adherence among recipients of vascularized composite allografts. SAGE Open Med 2020; 8:2050312120940423.
Huelsboemer L, Boroumand S, Kochen A, et al. Immunosuppressive strategies in face and hand transplantation: a comprehensive systematic review of current therapy regimens and outcomes. Front Transplant 2024; 3:1366243.
Grosu-Bularda A, Hodea FV, Zamfirescu D, et al. Exploring costimulatory blockade-based immunologic strategies in transplantation: are they a promising immunomodulatory approach for organ and vascularized composite allotransplantation? J Pers Med 2024; 14:322.
Giannis D, Moris D, Cendales LC. Costimulation blockade in vascularized composite allotransplantation. Front Immunol 2020; 11:544186.
Kollar B, Pomahac B, Riella LV. Novel immunological and clinical insights in vascularized composite allotransplantation. Curr Opin Organ Transplant 2019; 24:42–48.
Messner F, Fischer A-C, Runggaldier E, et al. Mechanical irritation in vascularized composite tissue allotransplantation triggers localized skin rejection. Transplantation 2020; 104:956–969.
Lopdrup RG, Turk M, Win TS, et al. Seasonal variability precipitating hand transplant rejection? Transplantation 2017; 101:e313.
Kaufman CL, Kanitakis J, Weissenbacher A, et al. Defining chronic rejection in vascularized composite allotransplantation—the American Society of Reconstructive Transplantation and International Society of Vascularized Composite Allotransplantation chronic rejection working group: 2018 American Society of Reconstructive Transplantation meeting report and white paper Research goals in defining chronic rejection in vascularized composite allotransplantation. SAGE Open Med 2020; 8:2050312120940421.
Kanitakis J. Defining chronic rejection in vascularized composite allografts – do we have reliable surrogates to look for? Curr Opin Organ Transplant 2023; 28:440–445.
Ng ZY, Lellouch AG, Rosales IA, et al. Graft vasculopathy of vascularized composite allografts in humans: a literature review and retrospective study. Transplant Int 2019; 32:831–838.
Conrad A, Petruzzo P, Kanitakis J, et al. Infections after upper extremity allotransplantation: a worldwide population cohort study, 1998-2027. Transpl Int 2019; 32:693–701.
Rifkin WJ, Manjunath AK, Kantar RS, et al. A Comparison of immunosuppression regimens in hand, face, and kidney transplantation. J Surg Res 2021; 258:17–22.
Ietto G, Gritti M, Pettinato G, et al. Tumors after kidney transplantation: a population study. World J Surg Oncol 2023; 21:18.